Gilead Requests FDA to Rescind Remdesivir’s Orphan Drug Designation
By Rajaneesh Karimpurath Gopinath, Ph.D. In a total U-turn, Gilead Sciences has now requested the U.S. Food and Drug Administration (USFDA) to rescind the orphan drug designation (ODD) granted to …
Read More